HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel P Hermans Selected Research

Type 2 Diabetes Mellitus (MODY)

2/2022Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.
6/2021Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines.
6/2020COVID-19 in diabetic patients: Related risks and specifics of management.
1/2020Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
11/2019Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes.
6/2019Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in "Real-World" Management of Type 2 Diabetes Mellitus: The G-FORCE Study.
1/2019The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
1/2018Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes.
1/2018[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.
9/2017The mixed benefit of low lipoprotein(a) in type 2 diabetes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel P Hermans Research Topics

Disease

26Type 2 Diabetes Mellitus (MODY)
02/2022 - 02/2005
21Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2022 - 11/2008
18Dyslipidemias (Dyslipidemia)
01/2020 - 11/2008
12Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2008
12Insulin Resistance
04/2019 - 02/2005
10Hypertension (High Blood Pressure)
06/2022 - 10/2009
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2022 - 04/2003
4Hypertriglyceridemia
06/2022 - 09/2012
4Obesity
01/2021 - 11/2008
3Overweight
01/2021 - 01/2019
3Albuminuria
01/2021 - 07/2011
3Coronary Disease (Coronary Heart Disease)
12/2019 - 02/2010
3Diabetes Complications
01/2018 - 07/2011
2Abdominal Obesity
06/2022 - 01/2018
2Heart Failure
02/2022 - 09/2016
2COVID-19
02/2022 - 06/2020
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2021 - 12/2017
2Atherosclerosis
01/2019 - 01/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 04/2017
2Diabetes Mellitus
05/2016 - 03/2014
2Sarcopenia
10/2012 - 05/2012
2Glucose Intolerance
05/2007 - 02/2005
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
02/2022
1Severe Acute Malnutrition
12/2021
1Hypotension (Low Blood Pressure)
01/2021
1Proteinuria
01/2021
1Left Ventricular Dysfunction
01/2021
1Cardiogenic Shock
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Hyperbilirubinemia
01/2021
1Ketosis
06/2020
1Lactic Acidosis
06/2020
1Chronic Renal Insufficiency
01/2020
1Hyperinsulinism (Hyperinsulinemia)
04/2019
1Hypoglycemia (Reactive Hypoglycemia)
01/2018
1Hyperthyroidism
12/2017
1Myalgia
12/2017
1Thyrotoxicosis
12/2017
1Body Weight (Weight, Body)
02/2016
1Hyperglycemia
01/2016
1Kidney Diseases (Kidney Disease)
03/2014
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2014

Drug/Important Bio-Agent (IBA)

18LipidsIBA
01/2021 - 04/2009
17Glucose (Dextrose)FDA LinkGeneric
02/2022 - 02/2005
16oxidized low density lipoproteinIBA
06/2022 - 04/2009
12Triglycerides (Triacylglycerol)IBA
01/2021 - 11/2008
11LDL CholesterolIBA
06/2022 - 11/2008
11HDL CholesterolIBA
06/2022 - 11/2008
10Insulin (Novolin)FDA Link
01/2021 - 02/2005
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2021 - 02/2010
5ApolipoproteinsIBA
11/2019 - 11/2008
4Lipoprotein(a)IBA
06/2021 - 09/2017
4Metformin (Glucophage)FDA LinkGeneric
01/2021 - 10/2012
4CreatinineIBA
01/2021 - 04/2003
4CholesterolIBA
12/2019 - 12/2009
3SodiumIBA
02/2022 - 01/2018
3PPAR alphaIBA
01/2021 - 01/2019
3Pharmaceutical PreparationsIBA
01/2021 - 12/2009
3Biological ProductsIBA
01/2021 - 12/2017
3Biomarkers (Surrogate Marker)IBA
11/2019 - 12/2009
3C-Reactive ProteinIBA
11/2019 - 05/2012
3HDL LipoproteinsIBA
04/2019 - 11/2008
3Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2019 - 03/2014
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2018 - 11/2008
3Fenofibrate (CiL)FDA LinkGeneric
01/2018 - 05/2010
2Sodium-Glucose Transport ProteinsIBA
02/2022 - 02/2022
2Sodium-Glucose Transporter 2 InhibitorsIBA
02/2022 - 06/2020
2Rosuvastatin Calcium (Crestor)FDA Link
06/2021 - 05/2016
2AlbuminsIBA
01/2021 - 08/2020
2(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
01/2021 - 01/2020
2Lipoproteins (Lipoprotein)IBA
10/2018 - 01/2018
2Blood Glucose (Blood Sugar)IBA
01/2018 - 02/2016
2AntioxidantsIBA
12/2017 - 07/2009
2Apolipoproteins B (ApoB)IBA
07/2014 - 02/2011
2AntibodiesIBA
02/2014 - 01/2014
2Uric Acid (Urate)IBA
10/2012 - 07/2009
2Cystatin CIBA
10/2012 - 04/2003
1ORALIT (ORS)IBA
06/2022
1Butyrates (Butyrate)IBA
01/2022
1DeuteriumIBA
12/2021
1DobutamineFDA LinkGeneric
01/2021
1EndocannabinoidsIBA
01/2021
1VildagliptinIBA
06/2019
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2019
1Ezetimibe (Zetia)FDA Link
01/2018
1Antihypertensive Agents (Antihypertensives)IBA
01/2018
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2018
1Fibric Acids (Fibrates)IBA
01/2018
13,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
12/2017
1Thyroid HormonesIBA
12/2017
1red yeast riceIBA
12/2017
1olive extractIBA
12/2017
1Simvastatin (Zocor)FDA LinkGeneric
05/2016
1Atorvastatin (Lipitor)FDA Link
05/2016
1Hemoglobins (Hemoglobin)IBA
03/2014
1AutoantibodiesIBA
02/2014
1glutamate decarboxylase 2IBA
02/2014

Therapy/Procedure

13Therapeutics
06/2021 - 05/2007
3Glycemic Control
06/2020 - 09/2017
1Artificial Respiration (Mechanical Ventilation)
06/2020